DocGo Posts Q2 Loss Amid Migrant Program Wind-Down, Acquires Hicuity Health.

DocGo's Q2 2026 results showed a GAAP loss per share of -$0.16 and revenue of $73.42 million, both missing consensus expectations of -$0.10 per share and about $75.35 million in revenue.
Mobile Health Services revenue excluding migrant-related programs rose 78% year over year to $21.4 million, signaling strong growth in core services despite the wind-down of migrant programs.
Medical Transportation Services revenue was $52.0 million in the quarter, up from $49.6 million in the prior-year quarter.
DocGo’s CEO emphasized that integrating Hicuity Health moves the company toward a holistic, tech-powered platform that bridges hospital and home, aiming to deliver care across the entire continuum.
Analyst coverage around the quarter depicts a mixed view, with a consensus Hold rating and an average price target of about $2.38, reflecting cautious sentiment amid a narrow trading range.
DocGo posted Q2 2026 revenue of $73.4 million, down from $80.4 million a year earlier, missing analyst expectations of about $75.4 million, according to Investing.com. The company also reported a GAAP net loss of $18.0 million, or $0.16 per share, worse than the consensus estimate of -$0.10 per share.
Alongside the results, DocGo announced a deal to acquire virtual-care provider Hicuity Health, aiming to build what its CEO called a "holistic, tech-powered platform" that bridges hospital and home care, MarketWatch reported.
The year-over-year revenue decline was not a sign of core weakness, DocGo argued. Migrant-related programs, now winding down, dragged overall numbers lower. Strip those out, and revenue actually rose 19% year over year, according to Quiver Quant.
Mobile Health Services revenue, excluding migrant programs, jumped 78% year over year to $21.4 million. Medical Transportation Services also grew, rising from $49.6 million to $52.0 million in the quarter, per TradingView.
DocGo signed a definitive agreement to acquire Hicuity Health, a telehealth platform. Hicuity generated about $65 million in trailing-12-month revenue and $4.5 million in adjusted EBITDA, according to Quiver Quant. The deal positions DocGo to deliver care across both physical and virtual settings.
To help fund the deal, Perceptive Advisors committed up to $50 million in additional debt financing. DocGo's CEO said the acquisition moves the company toward serving patients "across the entire continuum" of care, from hospital to home, MarketWatch reported.
DocGo narrowed its 2026 revenue guidance to $305 million to $310 million. But the company also cut its adjusted EBITDA outlook. It now projects a full-year adjusted EBITDA loss of $17 million to $22 million, according to Investing.com.
For Q2 alone, adjusted EBITDA came in at a loss of $6.3 million. Gross margin was 26.9% on a GAAP basis and 30.5% on an adjusted basis. The company held $48.1 million in cash as of June 30, 2026, per TradingView.
Analyst sentiment around DocGo remains guarded. The consensus rating is Hold, with an average price target of about $2.38, according to Investing.com. That reflects a narrow trading range and limited near-term upside in analysts' views.
The Q2 miss on both earnings and revenue added to investor caution. Still, the Hicuity deal and the strong growth in core Mobile Health Services could shift sentiment if DocGo shows it can execute, Investing.com noted.
Publishers
11
Articles
31
Reach
42